Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 27/01/22 → 26/01/27 |
Keywords
- phase 2 trial
- treatment safety
- treatment efficacy
- ovarian cancer
Clinical Trial Phase
- Phase II
PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression
- Webber, Kate (Primary Chief Investigator (PCI))
Project: Research